High-Dose Intranasal Bupropion Insufflation

Prim Care Companion CNS Disord. 2022 Mar 29;24(2):21cr03056. doi: 10.4088/PCC.21cr03056.

Authors

Kara Termulo^{1

2}, Miki Kiyokawa^{3

4}, Gerald Busch⁴

Affiliations

¹ John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii.
² Corresponding author: Kara Termulo, BS, John A. Burns School of Medicine, 651 Ilalo St, Honolulu, HI 96813 ([email protected]).
³ Department of Medicine, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii.
⁴ Department of Psychiatry, John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii.

PMID: 35364628
DOI: 10.4088/PCC.21cr03056

No abstract available

MeSH terms

Administration, Intranasal
Antidepressive Agents, Second-Generation* / adverse effects
Bupropion / adverse effects
Humans
Insufflation* / adverse effects

Substances

Antidepressive Agents, Second-Generation
Bupropion